Embarr Downs, Inc. (OTCMKTS:EMBR) Seduces Buyers with Promotion, Marijuana Promises
Embarr Downs, Inc. (OTCMKTS:EMBR) is fighting for buyers- and it’s fighting dirty, with seventeen promotional emails counted this March, for a total budget of $59,500. The mid-range campaign finally managed to reach a mass of buyers on Thursday, to achieve record trading volumes. Still, EMBR grew only modestly, by 34% to a price of $0.335, as dollar volumes were a relatively low $543,000. 
In the past days, EMBR remained rather choppy, and is still without a clear trend, as its price level is relatively high compared to that of other booming stocks, and buying in is not so easy. But this company is busy setting up its future, and may yet spin its stock price to higher levels. A PR message early on Friday promised EMBR would be making a major announcement on April 22.
The double-whammy was that this major announcement contained the key word to booming success- this company would be transforming itself into yet another marijuana stock. EMBR is not embarrassed to say that the cannabis venture will expose it to a market with a $15 billion volume. However, we cannot know what chunk of this market EMBR will get, and for now it is mostly vying for investors’ attention, aided by a mere 45 million shares in float and a relatively low market price of $15 million.
Another lure is the news for an extra dividend of $0.0001 for shareholders registered as of April 2014, in addition to the usual $0.01 per share annual dividend. This is almost all we know of the company, since its financial sheets are, for an unknown reason, scrubbed clean on almost all landing pages, and there are no SEC data either.
We have not met EMBR until now, and it has a patchy history of name changes, including two name changes and a penalty from the Secretary of State of the State of Florida for failure to file annual report, all the way back in 2001. But those are minor red flags compared to the danger of extreme exuberance as EMBR starts to lure in investors with a brand new promise.
EBMR plans specifically to enter into cannabis market and the legal marijuana market through two newly formed subsidiaries, Embarr Farms and Hemp Fish Water. EMBR plans to invest in aquaculture plants, economical establishments that breed easy-to-raise fish such as tilapia. In fact, EMBR won’t be raising cannabis itself, but will try to produce and market a form of fertilizer from the pond water, to be sold to small marijuana farms.
This is indeed a roundabout way to call the firm a “marijuana company”, but it may be enough for shareholders. In the last couple of weeks, the inflow of new entrants into legal cannabis business is shrinking a bit, so each novel ticker should be met with enthusiasm. But most newcomers are never bold enough to claim a dispensary license of their own, and instead rely on side services.
Even one of the sector leaders, Terra Tech, Corp. (OTCMKTS:TRTC) is still clinging to traditional hydroponics farming and is yet to announce revenues from medical marijuana sales. TRTC is now back above the dollar after a few days of seeking direction, at $1.06.
Growilife, Inc. (OTCBB:PHOT) is also using an indirect model, being a supplier of hydroponics systems. PHOT is stepping upward for now, and is holding at $0.55.
Keep in mind that the latest spike of volumes is due to the Stockoftheweek.net email, and avoid betting too much on the inherent upward potential of this stock.
